Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)

8 Feb 2024

Abstract excerpt

BACKGROUND: Moyamoya disease (MMD) is a rare and complex cerebrovascular disorder characterized by the progressive narrowing of the internal carotid arteries and the formation of compensatory collateral vessels. The etiology of MMD remains enigmatic, making diagnosis and management challenging. The MOYAOMICS project was initiated to investigate the molecular underpinnings of MMD and explore potential diagnostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cerebrovascular and Carotid Artery Diseases
Share to Moyamoya disease diagnosis and treatment
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38326922
DOI: 10.1186/s41016-024-00358-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiomics and blood-based biomarkers of moyamoya disease: protocol of Moyamoya Omics Atlas (MOYAOMICS)PMID 38326922Read ↗

Identification of diagnostic markers for moyamoya disease by combining bulk RNA-sequencing analysis and machine learningSemantic proximity Read ↗

Moyamoya BiomarkersSemantic proximity Read ↗

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identificationSemantic proximity Read ↗

In-depth cerebrovascular lipidomics profiling for discovering novel biomarkers and mechanisms in moyamoya and intracranial atherosclerotic diseaseSemantic proximity Read ↗

Unraveling the Dyslipidemic Landscape in Moyamoya Disease: O x LDL as a Key BiomarkerSemantic proximity Read ↗

Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular DiseasesSemantic proximity Read ↗

Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.Semantic proximity Read ↗

Transcriptome-wide analysis of intracranial artery in patients with moyamoya disease showing upregulation of immune response, and downregulation of oxidative phosphorylation and DNA repairSemantic proximity Read ↗

A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya DiseaseSemantic proximity Read ↗

Identification of the potential role of S1PR1 in adult moyamoya disease based on multiple bioinformatics analysis and experimental verificationSemantic proximity Read ↗

Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disordersSemantic proximity Read ↗

Single-cell sequencing analysis of peripheral blood in patients with moyamoya diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.